三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
戈来雷塞和AST24082(JAB-3312)的临床布局
戈来雷塞和AST24082(JAB-3312)的临床布局
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:142KB
图片尺寸:1571*707
同报告图片
/
4
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
所属报告:
艾力斯-公司深度报告:商业化成绩显著产品矩阵持续拓宽-250707(18页).pdf
打包全文图表
相关数据
图表20JAB-BX600的作用机制
收藏
行业数据
2026-02-25
原图定位
查看详情
戈来雷塞在胰腺癌及泛瘤种的临床数据
5aW955qE77yM5Lul5LiL5piv6K+l5Zu+54mH5Lit55qE5pWw5o2u6KGo5qC85ZKM6LWE5paZ5p2l5rqQ77yaCgp8IOeWvueXheexu+WeiyB8IE9SUiB8IG1QRlMgfCBtT1MgfAp8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8CnwgUERBQyB8IDQxLjklICgxNC8zMSkgfCA1LjYgbSB8IDEwLjcgbSB8Cnwg5rOb55ik56eNIHwgY09SUiA1Ny45JSAoMTEvMTkpIHwgRENSIDg0LjIlICgxNi8xOSkgfCAtIHwKCui1hOaWmeadpea6kO+8muWKoOenkeaAnTIwMjTlubTmipXotYTogIXkuqTmtYHmnZDmlpnvvIznlKzlhbTor4HliLjnoJTnqbbmiYA=
收藏
行业数据
2025-07-14
原图定位
查看详情
胰腺癌治疗数据:戈来雷塞疗效及安全性数据优异
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
收藏
行业数据
2025-03-07
原图定位
查看详情
一线KRASG12CNSCLC治疗:戈来雷塞+JAB-3312具有优异的疗效和安全性数据(非头对头对比)
fCDljoLllYYgfCDnlKjoja/mlrnmoYggfCBOIHwgT1JSIHwgRENSIHwgbVBGUyB8IG1PUyB8IOKJpTPnuqdUUkFFIHwKfC0tLS0tLXwtLS0tLS0tLS0tfC0tLS0tLXwtLS0tLS18LS0tLS0tfC0tLS0tLXwtLS0tLS18LS0tLS0tLS0tLXwKfCDliqDnp5HmgJ0v6Im+5Yqb5pavIHwg6IGU5ZCIIFNISVAyaSB8IDEwMiAgfCA2NC43JSB8IDEwMCUgfCAxMi4yIHwgLSB8IDQxLjklIHwKfCDlirLmlrkv5L+h6L6+55Sf54mpIHwg6IGU5ZCI6KW/5aal5piU5Y2V5oqXIHwgMzMgICB8IDgxLjglIHwgOTMuOCUgfCAtIHwgLSB8IDE3LjUlIHwKfCDnm4rmlrnnlJ/niakv5q2j5aSn5aSp5pm0IHwg6IGU5ZCIIEZBS2kgfCAzMyAgIHwgODcuNSUgfCAtIHwgNi42IHwgLSB8IDE4LjElIHwKfCDlronov5sgfCDogZTlkIjljJbnlpcgfCAzMCAgIHwgODguOSUgfCAtIHwgLSB8IDIwLjYgfCA4OS43JSB8CnwgQk1TL+WGjem8juWMu+iNryB8IOiBlOWQiCBQRC0xIOWNleaKlyB8IDUxICAgfCA2MyUgfCA4NCUgfCAtIHwgLSB8IDY1JSB8CgrotYTmlpnmnaXmupDvvJoyMDI0IEVTTU8sIDIwMjQgQVNDTywgMjAyMyBFU01PLCDjgIpBIHNpbmdsZS1hcm0sIHBoYXNlIElJIHN0dWR5IG9mIHNvdG9yYXNpYiBwbHVzIGNhcmJvcGxhdGluL3BlbWV0cmV4ZWQgaW4gYWR2YW5jZWQ=
收藏
行业数据
2025-03-07
原图定位
查看详情
二线KRASG12CNSCLC治疗:国产抑制剂数据优异,戈来雷塞数据与竞品整体类似(非头对头对比)
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
收藏
行业数据
2025-03-07
原图定位
查看详情
SHP2抑制剂竞争格局温和,JAB-3312为全球唯一进入III期试验的产品,进展全球领先
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
收藏
竞争格局
2025-03-07
原图定位
查看详情
戈来雷塞有望成为我国第三款获批上市的小分子KRASG12C抑制剂
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
收藏
行业数据
2025-01-16
原图定位
查看详情
戈来雷塞疗效和安全性俱佳
fCDku6Plj7cv55m76K6w5Y+3IHwg5oiI6Zu36Zu35aGeIHwg5oiI5p2l6Zu35aGeIHwg5qC86Zu36Zu35aGeIHwg5rCf5rO96Zu35aGeIHwKfC0tLS0tLXwtLS0tLS18LS0tLS0tfC0tLS0tLXwtLS0tLS18Cnwg6YCC5bqU55eHIHwgMkwgS1JBUyBHMTJDIOeqgeWPmCBOU0NMQyB8IDJMIEtSQVMgRzEyQyDnqoHlj5ggTlNDTEMgfCAyTCBLUkFTIEcxMkMg56qB5Y+YIE5TQ0xDIHwgMkwgS1JBUyBHMTJDIOeqgeWPmCBOU0NMQyB8Cnwg5Lq65pWwIHwgTj0xMTkgfCBOPTcwIHwgTj0xMjMgfCBOPTExNiB8Cnwg5YiG5pyfIHwgSS9JSeacnyB8IEkvSUnmnJ8gfCBJSeacnyB8IEkvSUnmnJ8gfAp8IOe7hOWQjS/kurrmlbAgfCDor5Xpqoznu4QgKE49MTE5KSB8IOivlemqjOe7hCAxIChOPTMwKSB8IOivlemqjOe7hCAyIChOPTQwKSB8IOivlemqjOe7hCAoTj0xMjMpIHwg6K+V6aqM57uEIChOPTExNikgfAp8IOWIhue7hOeJueW+gSB8IOaIiOmbt+mbt+WhniB8IDQwME1HIFFELCDmiIjmnaXpm7floZ4gfCA4MDBNRyBRRCwg5oiI5p2l6Zu35aGeIHwgNjAwTUcgQklELCDmoLzpm7fpm7floZ4gfCA2MDBNRyBCSUQsIOawn+azvembt+WhniB8CnwgRENSIHwgODYuMyUgfCA5MCUgfCA5NSUgfCA4OC42JSB8IDkwLjUlIHwKfCBtRG9SIHwgTlIgfCA2Ljltb250aHMgfCBOUiB8IDEyLjc4bW9udGhzIHwgOC4zbW9udGhzIHwKfCBPUlIgfCA0Ny45JSB8IDM2LjclIHwgNDIuNSUgfCA0OS42JSB8IDQ5LjElIHwKfCBtUEZTIHwgOC4ybW9udGhzIHwgNS42bW9udGhzIHwgOS42bW9udGhzIHwgNy41Nm1vbnRocyB8IDkuN21vbnRocyB8CnwgbU9TIHwgMTMuNm1vbnRocyB8IE5SIHwgTlIgfCBOUiB8IE5SIHwKfCBUUkFFICg+PWdyYWRlIDMpIHwgMzkuNSUgfCA0OS42JSB8IDQxLjQlIHwgNDEuNCUgfCA0MS40JSB8CgrotYTmlpnmnaXmupDvvJpJbnNpZ2h044CB5byA5rqQ6K+B5Yi456CU56m25omA
收藏
行业数据
2025-01-16
原图定位
查看详情
JAB-21822全球临床管线布局(截止2023年10月27日)
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
收藏
其它
2024-01-17
原图定位
查看详情
第二代JAB-3312与第一代JAB-3068结构及其结合位点
fCDnrKzkuIDku6NTSFAy5oqR5Yi25YmC57uT5ZCI5L2N54K5IHwg56ys5LqM5LujU0hQMuaKkeWItuWJgi1KQUItMzMxMue7k+WQiOS9jeeCuSB8CnwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfAp8ICB8
收藏
其它
2024-01-17
原图定位
查看详情
JAB-2485分子结构
fCDlm740MSB8IEpBQi0yNDg15YiG5a2Q57uT5p6EIHwKfC0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCBKQUItMjQ4NSB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8ICB8IA==
收藏
其它
2024-01-17
原图定位
查看详情
JAB-X1800分子结构示意
fCDpobnnm64gfCDmj4/ov7AgfAp8LS0tLS0tfC0tLS0tLXwKfCBKQUItWDE4MDAgfCBDRDczLVNUSU5HIGlBREMgfAp8IFNUSU5HIGFnb25pc3QgfCBKQUItMjc2NzAgfAp8IENENzMgYW50aWJvZHkgfCBKQUItQlgxMDIgfAoK6LWE5paZ5p2l5rqQ77ya44CKSkFCLVgxODAwOiBhIHBvdGVudCBpbW11bm9zdGltdWxhdG9yeSBhbnRpYm9keS1kcnVnIGNvbmp1Z2F0ZSAoaUFEQykgdGFyZ2V0aW5nIENENzPjgIs=
收藏
其它
2024-01-17
原图定位
查看详情
JAB-3312单药剂量爬坡DCR50%(N=12)
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
收藏
行业数据
2022-12-13
原图定位
查看详情
JAB-3312和JAB-21822有显著协同作用
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
收藏
行业数据
2022-12-13
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
根据艾力斯 2024 年年报,公司于 2024 年 8 月从加科思引进 KRAS G12C 抑制剂戈来雷塞和 SHP2 抑制剂 AST24082。KRAS G12C 突变在NSCLC 发生率为 4%,对应约每年 2.5 万人晚期新发患者。戈来雷塞用于KRAS G12C 突变二线 NSCLC 的 NDA 申请已于 2024 年 5 月获得优先审评,有望成为国产第三家获批二线肺癌的产品,对比竞品具备安全性优势;一线则为戈来雷塞与 AST24082 联用,其 III 期注册性临床已于 2024 年 8 月完成首例患者给药,是该适应症国内首个实现患者入组的注册临床。
行业数据
原图定位
当前图表所属:
艾力斯-公司深度报告:商业化成绩显著产品矩阵持续拓宽-250707(18页).pdf
部分第三代EGFR-TKI一线治疗EGFR突变NSCLC的PFS数据对比
阿美替尼ARTS研究II-IIIB期患者DFS
奥希替尼ADAURA研究II-IIIA期患者DFS
伏美替尼一线治疗不良反应谱(非头对头)
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》